AN Venture Partners

Building blockbuster biotech companies leveraging science from Japan.

AN Venture Partners is a venture capital fund investing in biotech. We aim to build blockbuster biotech companies primarily focusing on science from Japan. AN Ventures was founded with support from the Japanese government and ARCH Venture Partners.

Source: Focus on Japanese science and innovations, a significant scientific arbitrage opportunity
Build: Maximize value creation and capture by building companies in the top global ecosystem for biotech
Finance: Syndicate with top global venture investors to maximize success, and bring attention to Japanese science

Open jobs

No open jobs right now.

Websitehttps://an.vc/en/

Markets

Biotechnology Healthcare Investment Life Sciences Pharmaceuticals Venture Capital

Similar companies

RDiscovery

RDiscovery invests in and builds early-stage biotechnology companies, translating Japanese therapeutic discoveries into new ventures.

Saisei Ventures

Saisei Ventures builds and invests in early-stage biotechnology companies in cell and gene therapy and regenerative medicine, bridging Japanese science with global expertise from Cambridge and Tokyo.

Shinsei Capital Partners

Shinsei Capital Partners is a Japanese venture capital firm focused on life-science company creation and investment.

Nippon Venture Capital

Nippon Venture Capital invests in Japanese startups and supports their development from early stages toward growth and public markets.

BioFrontier Partners

BioFrontier Partners is a Tokyo-based venture capital firm investing in biotechnology, healthcare and life sciences companies, with consulting and post-investment technical support.

Ono Venture Investment

Ono Venture Investment invests in early-stage biotechnology companies aligned with pharmaceutical research.